drugset / Trial / NCT04227041
A Study of Pyrotinib Combined With Capecitabine for Metastatic HER-2 Positive Colorectal Cancer
Phase 1/2
Unknown
34 enrolled
Qingdao Zhixin Health Technology Co., Ltd.
The Affiliated Hospital of Qingdao University · collab
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the efficacy and safety of pyrotinib combined with capecitabine in patients with metastatic her-2 positive colorectal cancer after standard treatment.
Timeline
- Start
- 2020-01-10
- Primary completion
- 2021-01-10
- Completion
- 2023-01-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | — | — |
| Subject | Pyrotinib | Small molecule | — | — |